Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Comparsion of TCR-CDR3 sequencing of WT, STAT3ko, STAT3koPD-1ko donor T cells in the Liver and Gut of allogenetic HCT mouse recepients

ABSTRACT: We injected Thy1.2+ T cells from WT or STAT3ko or STAT3koPD-1ko C57BL/6 mice with T cell-depleted bone marrow cells from WT C57BL/6 mice into WT BALB/c recipients to establish acute GVHD model.

ORGANISM(S): Mus musculus

PROVIDER: GSE215164 | GEO | 2023/08/08

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Comparison of gene profile of WT, STAT3 KO and STAT3koPD-1ko donor T cells in the liver of allogenetic HCT mouse recepients

Project description:We injected Thy1.2+ T cells from WT or STAT3ko or STAT3koPD-1ko C57BL/6 mice with T cell-depleted bone marrow cells from WT C57BL/6 mice into WT BALB/c recipients to establish acute GVHD model.

2023-08-08 | GSE214506 | GEO

Comparison of gene profile of WT, STAT3 KO donor T cells in the spleen of allogenetic HCT mouse recepients

Project description:We injected Thy1.2+ T cells from WT or STAT3ko C57BL/6 mice with T cell-depleted bone marrow cells from WT C57BL/6 mice into WT BALB/c recipients to establish acute GVHD model.

2023-08-08 | GSE214529 | GEO

Comparsion of TCR-CDR3 sequencing of WT, STAT3ko, STAT3koPD-1ko donor T cells in the Liver and Gut of allogenetic HCT mouse recepients

Project description:Comparsion of TCR-CDR3 sequencing of WT, STAT3ko, STAT3koPD-1ko donor T cells in the Liver and Gut of allogenetic HCT mouse recepients

| PRJNA889021 | ENA

AURKA Expression in allogeneic HCT-recipients

Project description:Graft versus host disease (GVHD) is the most common complication of hematopoietic stem cell transplant (HCT). However, our understanding of the molecular pathways that cause this disease remains incomplete, leading to inadequate treatment strategies. To address this, we measured the gene expression profile of non-human primate (NHP) T cells during acute GVHD (GSE73723). Within these profiles we discovered potentially druggable targets not previously implicated in GVHD, prominently including aurora kinase A (AURKA). In this study, we performed a planned comparison of AURKA gene expression in HCT-recipients with clinical GVHD and compared it to expression in HCT-recipients without clinical GVHD.

2015-11-29 | GSE73809 | GEO

Donor regulatory T cells rapidly adapt to recipient tissues to control acute graft-versus-host disease [TCR-seq]

Project description:Adoptive transfer of donor regulatory T cells (Treg) is a promising treatment option for Graft-versus-Host disease (GvHD), but has not yet found its way into routine clinical practice. To map distinctive properties of protective Treg (generated by either polyclonal or allogeneic in vitro expansion), we followed their fate in recipient organs (spleen, liver, colon) in a prophylactic mouse model of MHC-mismatched bone-marrow transplantation (BMT). Using comprehensive gene expression and T cell receptor profiling, we show that both in vitro expansion protocols generated Treg products that preserved hallmark Treg properties, ameliorated GvHD symptoms, retained their phenotypic plasticity and rapidly acquired organ-specific gene expression profiles after BMT, comparable to their tissue-resident counterparts. When co-transplanted with GvHD-inducing T cells, Treg enabled hallmark suppressive and cytotoxic features, most evidently in the colon. Dominant Treg T cell receptor clonotypes were evenly distributed between organs and across recipients, suggesting a major role of ubiquitous alloantigen-specific Treg in controlling GvHD. Effective protection inversely correlated with the relative abundance of organ-specific Treg, that were transcriptionally distinct, less “activated” and preferentially accumulated in the colon of recipients receiving polyclonally expanded Treg. In summary, we provide a detailed atlas of Treg selection and adaptation in the prophylactic therapy of GvHD.

2024-01-01 | GSE223797 | GEO

Effect of hBD-2 treatment on gene expression in the colon of acute graft-versus-host disease (GVHD) mice

Project description:Wildtype (WT) BALB/c mice were treated with allogeneic hematopoietic cell transplantation (allo-HCT) in order to induce acute GVHD. C57BL/6 mice were used bone marrow (BM) and T cell donor mice. We studied the effect of oral hBD-2 treatment versus vehicle (PBS) control treatment on the gene expression in the colon, as main GVHD target organ.

2022-12-23 | GSE190796 | GEO

Transcriptome Profiling in NHP-HCT recipients

Project description:Graft versus host disease (GVHD) is the most common complication of hematopoietic stem cell transplant (HCT). However, our understanding of the molecular pathways that cause this disease remains incomplete, leading to inadequate treatment strategies. To address this, we measured the gene expression profile of non-human primate (NHP) T cells during acute GVHD. This transcriptome analysis enables an unsupervised approach to the identification of targets for disease control using a model with an immune system that closely overlaps with the human and has a high degree of cross-reactivity with human antibody-based therapeutics.

2015-11-29 | GSE73723 | GEO

Transcription profiling of mouse ES cells: WT, HIF-1KO, HIF-2KO cells treated under 21% or 1.5% oxygen to indentify hypoxia induced genes

Project description:WT, HIF-1KO, HIF-2KO ES cells were treated under 21% or 1.5% oxygen. HIF-1 target genes will be identified in HIF-2KO ES cell while HIF-2 target genes will be identified in HIF-1KO ES cells. WT ES cells expressing both HIF-1 and HIF-2 protein will be useful to identify hypoxia indicible genes induced by HIF-1 and HIF-2.

2006-07-01 | E-MEXP-392 | biostudies-arrayexpress

Transcriptome Profiling in KY1005-treated NHP HCT-recipients

Project description:Graft versus host disease (GVHD) is the most common complication of hematopoietic stem cell transplant (HCT). However, our understanding of the molecular pathways that cause this disease remains incomplete, leading to inadequate treatment strategies. To address this, we measured the gene expression profile of non-human primate (NHP) T cells during acute GVHD. In this study we specifically interrogated the transcriptional signatures of animals treated with KY1005 monotherapy and KY1005/Sirolimus combination therapy

2017-08-01 | GSE99644 | GEO

Transcriptome Profiling in KY1005-treated NHP HCT-recipients

Project description:Graft versus host disease (GVHD) is the most common complication of hematopoietic stem cell transplant (HCT). However, our understanding of the molecular pathways that cause this disease remains incomplete, leading to inadequate treatment strategies. To address this, we measured the gene expression profile of non-human primate (NHP) T cells during acute GVHD. In this study we specifically interrogated the transcriptional signatures of animals treated with FR104 monotherapy and FR104/Sirolimus combination therapy

2018-06-21 | GSE116070 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data